XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Equity
 6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Equity Equity
The following summarizes the changes in equity for the six months ended June 30, 2023 and 2022 (dollars in thousands):
Common
stock		Additional
paid-in
capital		Accumulated
earnings
less
dividends		Accumulated
other
comprehensive
income (loss)		Total stockholder's equityNoncontrolling interestsTotal
equity
Balance at December 31, 2022$1,400 $10,765,431 $485,221 $1,424 $11,253,476 $77 $11,253,553 
Net income attributable to common stockholders— — 146,902 — 146,902 — 146,902 
Loss on cash flow hedges, net— — — (340)(340)— (340)
Cash flow hedge losses reclassified to earnings— — — 354 354 — 354 
Change in redemption value of redeemable noncontrolling interest— — (286)— (286)— (286)
Dividends declared to common stockholders ($1.65 per share)
— — (230,958)— (230,958)— (230,958)
Issuance of common stock, net of withholdings1 (11,554)1,590 — (9,963)— (9,963)
Repurchase of common stock, including repurchase costs— (539)(590)— (1,129)— (1,129)
Amortization of deferred compensation— 11,123 — — 11,123 — 11,123 
Balance at March 31, 2023$1,401 $10,764,461 $401,879 $1,438 $11,169,179 $77 $11,169,256 
Net income attributable to common stockholders— — 367,923 — 367,923 — 367,923 
Gain on cash flow hedges, net— — — 8,826 8,826 — 8,826 
Cash flow hedge losses reclassified to earnings— — — 354 354 — 354 
Change in redemption value of redeemable noncontrolling interest— — (367)— (367)— (367)
Dividends declared to common stockholders ($1.65 per share)
— — (234,774)— (234,774)— (234,774)
Issuance of common stock, net of withholdings19 494,643 43 — 494,705 — 494,705 
Repurchase of common stock, including repurchase costs— (369)(413)— (782)— (782)
Amortization of deferred compensation— 10,424 — — 10,424 — 10,424 
Balance at June 30, 2023$1,420 $11,269,159 $534,291 $10,618 $11,815,488 $77 $11,815,565 
Common
stock		Additional
paid-in
capital		Accumulated
earnings
less
dividends		Accumulated
other
comprehensive
income (loss)		Total stockholder's equityNoncontrolling interestsTotal
equity
Balance at December 31, 2021$1,398 $10,716,414 $240,821 $(26,106)$10,932,527 $566 $10,933,093 
Net income attributable to common stockholders— — 262,044 — 262,044 — 262,044 
Gain on cash flow hedges, net— — — 10,155 10,155 — 10,155 
Cash flow hedge losses reclassified to earnings— — — 1,013 1,013 — 1,013 
Change in redemption value of redeemable noncontrolling interest— — (43)— (43)— (43)
Noncontrolling interest distribution and income allocation— — — — — (10)(10)
Dividends declared to common stockholders ($1.59 per share)
— — (222,373)— (222,373)— (222,373)
Issuance of common stock, net of withholdings1 (14,263)(1,501)— (15,763)— (15,763)
Amortization of deferred compensation— 9,176 — — 9,176 — 9,176 
Balance at March 31, 2022$1,399 $10,711,327 $278,948 $(14,938)$10,976,736 $556 $10,977,292 
Net income attributable to common stockholders— — 138,691 — 138,691 — 138,691 
Gain on cash flow hedges, net— — — 7,759 7,759 — 7,759 
Cash flow hedge losses reclassified to earnings— — — 1,013 1,013 — 1,013 
Change in redemption value of redeemable noncontrolling interest— — 168 — 168 — 168 
Noncontrolling interest distribution and income allocation— — — — — (6)(6)
Dividends declared to common stockholders ($1.59 per share)
— — (222,772)— (222,772)— (222,772)
Issuance of common stock, net of withholdings— 1,683 — — 1,683 — 1,683 
Amortization of deferred compensation— 14,183 — — 14,183 — 14,183 
Balance at June 30, 2022$1,399 $10,727,193 $195,035 $(6,166)$10,917,461 $550 $10,918,011 

As of June 30, 2023 and December 31, 2022, the Company's charter had authorized for issuance a total of 280,000,000 shares of common stock and 50,000,000 shares of preferred stock.

During the six months ended June 30, 2023, the Company:

i.issued 5,773 shares of common stock in connection with stock options exercised;
ii.issued 1,703 shares of common stock through the Company's dividend reinvestment plan;
iii.issued 152,708 shares of common stock in connection with restricted stock grants and the conversion of performance awards to shares of common stock;
iv.issued 2,000,000 shares of common stock in the settlement of the forward contracts, as discussed below;
v.issued 12,288 shares of common stock through the Employee Stock Purchase Plan;
vi.withheld 62,215 shares of common stock to satisfy employees' tax withholding and other liabilities;
vii.canceled 566 shares of restricted common stock upon forfeiture; and
viii.repurchased 11,800 common shares through the Stock Repurchase Program (as defined below).

Deferred compensation granted under the Company's Second Amended and Restated 2009 Equity Incentive Plan (the "2009 Plan") for the six months ended June 30, 2023 does not impact the Company's Condensed Consolidated Financial Statements until recognized as compensation cost.

The Company has a continuous equity program ("CEP") under which the Company may sell (and/or enter into forward sale agreements for the sale of) up to $1,000,000,000 of its common stock from time to time. During the three and six months ended June 30, 2023, the Company had no sales under this program. As of June 30, 2023, the Company had $705,961,000 remaining authorized for issuance under the CEP.
In addition to the CEP, during the three months ended June 30, 2023, the Company settled the outstanding forward contracts entered into in April 2022 (the "Equity Forward"), issuing 2,000,000 shares of common stock, net of offering fees and discounts for $491,912,000 or $245.96 per share.

The Company has a stock repurchase program under which the Company may acquire shares of its common stock in open market or negotiated transactions up to an aggregate purchase price of $500,000,000 (the "Stock Repurchase Program"). During the three and six months ended June 30, 2023, the Company repurchased 4,800 and 11,800 shares of common stock, respectively, at an average price of $162.93 per share and $161.96 per share, respectively. As of June 30, 2023, the Company had $314,237,000 remaining authorized for purchase under this program.